Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex

News

Warning over migraine drug

Posted 14 September 2021 PM

The TGA has updated the product information for Novartis' migraine drug Aimovig to include a warning about a potential causal relationship between the drug and hypertension.

The special warnings and precautions section now states that development of hypertension and worsening of pre-existing hypertension have been reported following the use of Aimovig, with cases requiring pharmacological treatment and sometimes hospitalisation.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Melb pharma registers first copy
Long list of generic versions of PBS-listed drugs